跳至主要内容
临床试验/NCT02866097
NCT02866097Unknown不适用

Strengthening the Delivery of Integrated Community Case Management (iCCM) in Two Districts of Eastern Province, Zambia

Zambia Center for Applied Health Research and Development1 个研究点 分布在 1 个国家目标入组 3,840 人开始时间: 2016年3月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
3,840
试验地点
1
主要终点
Composite percentage of children appropriately treated for malaria, diarrhea, and pneumonia.

研究概览

简要总结

This study will provide important evidence to the Ministry of Community Development, Mother and Child Health (MCDMCH) and the Ministry of Health (MOH) on how to effectively implement iCCM with a focus on improving both the flow of supplies to CHWs as well as the quality of their supervision and mentorship. The overall aim will be to determine whether improvements in supplies for community health workers (CHWs) and strengthened supervision result in improved early and appropriate treatment for children with malaria, pneumonia, and diarrhea in rural Zambia when compared to CHWs offering iCCM without this logistics and supervision support.

详细描述

The main objective of this study is to strengthen the delivery of integrated community case management (iCCM) of malaria, diarrhea, and pneumonia in Chadiza and Chipata Districts of Eastern Province, through mHealth supported improved supply chain management of iCCM commodities and enhanced supportive supervision of iCCM-trained CHWs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
1 Month 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age <5 years
  • Treatment for an iCCM condition (malaria, pneumonia, or diarrhea) by a CHW
  • Willingness of the child's caregiver to provide informed consent

排除标准

  • 未提供

结局指标

主要结局

Composite percentage of children appropriately treated for malaria, diarrhea, and pneumonia.

时间窗: Through study completion, up to six months

Defined as percentage of sick children under five years of age presenting with an i-CCM condition to an i-CCM trained health worker (CHW or a CHA) who received appropriate treatment for an iCCM condition (composite indicator): Appropriate treatment for malaria: received artemisinin-based combination therapy (ACT) for malaria for at least three days or Appropriate treatment for pneumonia: received amoxicillin for pneumonia for at least five days or Appropriate treatment for diarrhea: received zinc in addition to fluid from ORS packet or oral rehydration solution (ORS) liquid or homemade fluid for diarrhea

次要结局

  • a) Medicine availability (artemether-lumefantrine)(Through study completion, up to six months)
  • d) Average cost per iCCM contact(Through study completion, up to six months)
  • f) Medicine availability (amoxicillin)(Through study completion, up to six months)
  • b) Clinical supervision coverage(Through study completion, up to six months)
  • c) Virtual supervision coverage (via mobile technology)(Through study completion, up to six months)
  • e) Diagnostic availability(Through study completion, up to six months)
  • g) Medicine availability (ORS)(Through study completion, up to six months)
  • h) Medicine availability (Zinc)(Through study completion, up to six months)

研究者

发起方
Zambia Center for Applied Health Research and Development
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验